Cellerant Therapeutics is a biotechnology company with a portfolio of products based on the regulation of the hematopoietic (blood-forming) system. The company focuses on curative therapies for seriously ill patients.
Cellerant is developing a novel, cell-based medicine (Myeloid Progenitors / CLT-008) as a treatment for chemotherapy- and radiation-induced neutropenia as well as for Acute Radiation Syndrome. And we are applying our expertise in hematopoietic ontogeny to identify novel drug targets and therapeutic antibodies aimed at cancer stem cells.
Current Team (8)Update
Executive Director of Manufacturing and Process Sciences
Sr. Vice President, Regulatory, QA & Project Management
Vice President of Government Operations and Controller
President & CEO Board of Director
Vice President for Clinical Development
Vice President, Corporate Development
Chairman, Board of Directors
Vice President of Research & Development
Funding Rounds (9) - $96.2MUpdate
Board Members and Advisors (4)Update
1561 Industrial Road
San Carlos, CA 94070